Titan America SA Common Shares (TTAM)
15.72
-0.34 (-2.12%)
NYSE · Last Trade: Sep 13th, 6:16 PM EDT

Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a modest opening, just slightly higher than its initial pricing.
Via Talk Markets · February 9, 2025